Search Results for: nature

An arXiv for all of science? F1000 launches new immediate publication journal

Late last year, we published an invited commentary in Nature calling for science to more formally embrace post-publication peer review, and stop fetishizing the published paper. One of the models we cited was Faculty of 1000 (F1000), “in which experts flag important papers in their field.” So it’s not surprising that F1000 is announcing today … Continue reading An arXiv for all of science? F1000 launches new immediate publication journal

Case Western explains why it withdrew press release about Andrulis origin of life paper

The wild and woolly saga of the paper that claims to solve “the puzzle of the origin and evolution of cellular life in the universe” continues. Yesterday, Ivan wrote on his Tumblr about Case Western’s Erik D. Andrulis‘ paper, “Theory of the Origin, Evolution, and Nature of Life:”

Should Iran have nuclear power? Paper addressing question retracted for authorship issues

When Renewable and Sustainable Energy Reviews accepted a paper last year arguing that nuclear power is Iran’s “assured right,” the editor, Lawrence Kazmirski, thought the article would be at least somewhat controversial. He was right — but for the wrong reason. Shortly after publication, Kazmirski,  director of the National Center for Photovoltaics at the National Renewable … Continue reading Should Iran have nuclear power? Paper addressing question retracted for authorship issues

Sebastiani and Perls longevity genes work finds a new home in PLoS ONE following Science retraction

Today, without us having planned it, has become the day of retracted papers that found a new home. This morning, we posted an item about a chimp “culture” paper that was retracted from Biology Letters after its authors found some errors, and then published, with corrections, in the Journal of Human Evolution. This afternoon, we … Continue reading Sebastiani and Perls longevity genes work finds a new home in PLoS ONE following Science retraction

ORI roundup: Former SUNY grad student, two Kansas U researchers hit with sanctions

In two unrelated cases, the Office of Research Integrity (ORI) has sanctioned a grad student and a pair of colleagues, one of whom plagiarized and the other allowed the intellectual theft to go unchecked. We think the handling of these cases — both first noted briefly by The Chronicle of Higher Education — is worth noting.

So how peripheral was Dipak Das’ resveratrol work, really?

In the wake of the massive allegations of fraud by resveratrol researcher Dipak Das, other researchers in the field are clearly trying to distance themselves from the University of Connecticut scientist. Nir Barzilai told us yesterday, for example, that despite Das seemingly’ impressive publication record, “Rome was not built on Dr. Das.” Harvard’s David Sinclair went … Continue reading So how peripheral was Dipak Das’ resveratrol work, really?

A mega-correction, but no retraction, in the Journal of Cell Science

In our 2011 year-end post, we promised to keep …an eye on what may be an emerging trend: The mega-correction. We’ve seen errata notices that correct so many different errors, it’s hard to believe the paper shouldn’t have been retracted. It’s unclear what this means yet, but watch this space for coverage of more examples. … Continue reading A mega-correction, but no retraction, in the Journal of Cell Science

UConn resveratrol researcher Dipak Das fingered in sweeping misconduct case

The University of Connecticut, in what clearly seems like an attempt to get ahead of damaging news, has announced an “extensive” investigation into research misconduct involving one of its scientists, Dipak K. Das. According to a press release, the university has notified 11 journals that published Das’ work about the alleged fraud. One area of … Continue reading UConn resveratrol researcher Dipak Das fingered in sweeping misconduct case

Potti and colleagues retract 2008 JAMA paper

Anil Potti‘s retraction count is now eight with the withdrawal of a 2008 study in the Journal of the American Medical Association (JAMA). Here’s the notice, which appeared online in JAMA sometime yesterday:

The Year of the Retraction: A look back at 2011

If Retraction Watch was actually a business, as opposed — for the moment, anyway — to a labor of love for two guys with day jobs, 2011 would have been a very good year for business. It was a year that will probably see close to 400 retractions, including a number of high-profile ones, once … Continue reading The Year of the Retraction: A look back at 2011